Assistance Listing 93.847
Diabetes, Digestive, and Kidney Diseases Extramural Research
National Institutes of Health · Department of Health and Human Services
The verdict for a small nonprofit
Mostly repeat grantees: only 7% of awards go to new applicants. Apply with a strong track record or a partner who has won before.
Based on 2,443 new awards in FY2023–25. Organizations under $1M in revenue won 0% of the awards that went to nonprofits. The median award is $493,213. Expect about 134 days between posting and deadline.
- First-time winners
- 7%
- of new awards, last 3 FYs
- Nonprofit share
- 20%
- 69% higher ed · 0% gov't
- Under-$1M orgs
- 0%
- of nonprofit awards
- Median award
- $493K
- $234K – $1.5M middle half
- New awards, FY2025
- 638
- $568M committed to them
- Usually posts
- Jun
- annual · 134-day window
Open right now under this program
40 opportunities · from Grants.gov, checked every 10 minutes
Who won in FY2025
Largest recipients by dollars. From USAspending.
| Recipient | Type | State | Awards | Awarded |
|---|---|---|---|---|
| Regents of the University of Michigan | Higher ed | MI | 183 | $242,141,417 |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Other | PA | 136 | $197,423,376 |
| Washington University, the | Higher ed | MO | 133 | $179,320,167 |
| Trustees of the University of Pennsylvania, the | Higher ed | PA | 124 | $177,888,146 |
| Regents of the University of California, San Francisco, the | Higher ed | CA | 123 | $185,079,812 |
| The Regents of the University of Colorado | Higher ed | CO | 120 | $158,238,509 |
| Yale Univ | Higher ed | CT | 113 | $183,676,704 |
| The General Hospital Corporation | Nonprofit | MA | 98 | $148,716,434 |
| The Leland Stanford Junior University | Higher ed | CA | 95 | $153,214,255 |
| Mayo Clinic | Higher ed | MN | 95 | $149,594,880 |
New awards by fiscal year
Awards first made in each fiscal year; dollars are the total committed to that year's new awards over their life.
| FY | New awards | Committed | Median | Middle half |
|---|---|---|---|---|
| 2021 | 2,103 | $3.5B | $1.4M | $299K – $2.4M |
| 2022 | 939 | $1.5B | $1.2M | $324K – $2.4M |
| 2023 | 922 | $1.3B | $1.3M | $331K – $2.2M |
| 2024 | 883 | $1.1B | $1.2M | $318K – $1.9M |
| 2025 | 638 | $568M | $493K | $234K – $1.5M |
Past rounds
Every announcement under this listing that Grants.gov still lists. Use it to plan next year.
| Posted | Closed | Window | Announcement |
|---|---|---|---|
| 2026-10-16 | 2029-05-25 | 952 d | PAR-28-090 · Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) |
| 2026-10-15 | 2026-11-17 | 33 d | RFA-DK-27-122 · Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required) |
| 2026-10-06 | 2029-06-20 | 988 d | RFA-AI-27-018 · Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) |
| 2026-08-31 | 2026-11-06 | 67 d | RFA-DK-27-125 · Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required) |
| 2026-08-31 | 2026-11-09 | 70 d | RFA-DK-27-112 · Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) |
| 2026-08-31 | 2026-09-30 | 30 d | RFA-DK-27-127 · Cooperative Centers for Experimental Hematology (CCEHs) (U54- Clinical Trial Not Allowed) |
| 2026-08-31 | 2028-07-07 | 676 d | PAR-27-076 · Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional) |
| 2026-08-31 | 2026-11-09 | 70 d | RFA-DK-27-139 · Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required) |
| 2026-08-20 | forecast | — | RFA-DK-28-116 · Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed) |
| 2026-08-04 | forecast | — | RFA-DK-28-115 · Single Source Competition for Continuation of Understanding and Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed) |
| 2026-07-02 | forecast | — | RFA-DK-28-112 · NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional) |
| 2026-07-01 | forecast | — | RFA-DK-28-312 · KUH P30 Resource Core Center (P30 Clinical Trial Not Allowed) |
| 2026-07-01 | forecast | — | RFA-DK-28-313 · KUH U24 Center Coordinating Hub (U24 Clinical Trial Not Allowed) |
| 2026-07-01 | forecast | — | RFA-DK-28-114 · NIDDK Multi-Purpose Resource-Related, Multi-Component Research Services Centers Cooperative Agreement (U2C - Clinical Trial Optional) |
| 2026-06-30 | 2026-10-20 | 112 d | RFA-DK-27-120 · Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional) |
| 2026-06-22 | 2029-07-12 | 1116 d | PA-27-030 · Institutional Mentored Career Development Award (Parent K12) (Clinical Trials Not Allowed) |
| 2026-06-16 | 2027-02-10 | 239 d | RFA-DK-27-119 · Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional) |
| 2026-06-08 | 2029-05-25 | 1082 d | PA-27-034 · NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed) |
| 2026-06-08 | 2029-05-05 | 1062 d | PA-27-035 · NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed) |
| 2026-06-08 | 2026-10-09 | 123 d | RFA-DK-27-121 · Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required) |
| 2026-06-08 | 2026-10-09 | 123 d | RFA-DK-27-136 · Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed) |
| 2026-06-08 | 2029-05-05 | 1062 d | PA-27-036 · NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed) |
| 2026-06-04 | 2027-03-10 | 279 d | RFA-DK-27-108 · Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed) |
| 2026-06-04 | 2026-09-30 | 118 d | RFA-DK-27-109 · Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center (U24 Clinical Trial Not Allowed) |
| 2026-06-03 | 2026-07-10 | 37 d | RFA-DK-27-301 · Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed) |
| 2026-06-03 | 2026-07-10 | 37 d | RFA-DK-27-302 · Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed) |
| 2026-06-03 | 2026-07-10 | 37 d | RFA-DK-27-303 · Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed) |
| 2026-05-28 | 2027-04-05 | 312 d | PA-27-102 · NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) |
| 2026-05-28 | 2029-04-05 | 1043 d | PA-27-101 · NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) |
| 2026-05-28 | 2027-04-05 | 312 d | PA-27-100 · NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) |
| 2026-05-28 | 2029-04-05 | 1043 d | PAR-27-098 · SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) |
| 2026-05-27 | forecast | — | PAR-27-039 · Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) |
| 2026-05-20 | 2026-07-01 | 42 d | RFA-DK-27-126 · Kidney, Urologic, and Hematologic Diseases - Fostering the AdvanceMent of an Interactive Learning communitY - Coordinating Center (KUH-FAMILY) (U24- Clinical Trials Not Allowed) |
| 2026-05-20 | 2026-09-30 | 133 d | RFA-DK-27-147 · Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed) |
| 2026-05-13 | 2028-06-15 | 764 d | RFA-OD-27-005 · INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required) |
| 2026-05-12 | 2028-06-15 | 765 d | RFA-OD-27-004 · INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed) |
| 2026-05-07 | 2026-06-17 | 41 d | RFA-DK-27-146 · New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies (R01 - Clinical Trial Optional) |
| 2026-02-06 | 2026-03-10 | 32 d | RFA-DK-26-313 · Single Source for Continuation of the Accelerating Medicines Partnership (AMP) in Common Metabolic Diseases (CMD) Knowledge Portal (U01 Research Project (Cooperative Agreement) Clinical Trial not allowed) |
| 2026-02-05 | forecast | — | RFA-DK-27-138 · Single Source for Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Data Coordinating Center (DCC) |
| 2026-02-05 | forecast | — | RFA-DK-27-137 · Single Source: Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium- Renal and Environmental Science Core (U01-Clinical Trial Not Allowed) |
Common questions
How hard is it to win a grant under 93.847?
Mostly repeat grantees: only 7% of awards go to new applicants. Apply with a strong track record or a partner who has won before. Based on 2,443 new awards in FY2023–25. Organizations under $1M in revenue won 0% of the awards that went to nonprofits. The median award is $493,213. Expect about 134 days between posting and deadline.
How much does Diabetes, Digestive, and Kidney Diseases Extramural Research award?
In FY2025 the median new award was $493K; the middle half ran from $234K to $1.5M. 638 new awards were made, with $568M committed to them.
When does 93.847 usually post?
Over the last several years, new rounds most often posted in Jun with about 134 days to apply. The most recent round posted Oct 16, 2026.
Who runs this program?
Department of Health and Human Services (National Institutes of Health). Assistance Listing 93.847 on SAM.gov describes the authorizing statute and standard terms.
Sources: USAspending FY2021–25 award archive (2026-10-06); Grants.gov Search2 (fetched 2026-10-28); IRS EO BMF (fetched 2026-10-28). Award counts are new awards by fiscal year of first action. Shares are computed from award counts, not dollars; the under-$1M share covers the 62% of nonprofit awards that matched an IRS revenue record. Recipient type comes from the award record's business-type codes. Always confirm details in the official announcement.